Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

about

Utilizing proteomics to understand and define hypertension: where are we and where do we go?

P2860

Q58227790-4AAA82B1-18C0-41C8-9896-33232C7DA174

P2860

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Item

http://www.wikidata.org/entity/Q38639083

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immune system deregulation in ...... ressed developing albuminuria.

@en

type

Item

label

Immune system deregulation in ...... ressed developing albuminuria.

@en

prefLabel

Immune system deregulation in ...... ressed developing albuminuria.

@en

P1476

Immune system deregulation in ...... pressed developing albuminuria

@en

P2093

Fernando Vivanco

http://www.w3.org/2001/XMLSchema#string

Julián Segura

http://www.w3.org/2001/XMLSchema#string

Laura Gonzalez-Calero

http://www.w3.org/2001/XMLSchema#string

Marta Martin-Lorenzo

http://www.w3.org/2001/XMLSchema#string

Paula J Martinez

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.

STRING 8--a global view on proteins and their functional interactions in 630 organisms

Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury

Inflammation, immunity, and hypertensive end-organ damage

An update on immune system activation in the pathogenesis of hypertension

Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile.

A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima.

The immune system in hypertension

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.

A robust method for quantitative high-throughput analysis of proteomes by 18O labeling.

P2888

s41598-017-09042-2

P304

8894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09042-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan Antonio Lopez

Gloria Alvarez-Llamas

Fernando De la Cuesta

Montserrat Baldan-Martin

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091255900

http://www.w3.org/2001/XMLSchema#string

P698

28827575

http://www.w3.org/2001/XMLSchema#string

P932

5566220

http://www.w3.org/2001/XMLSchema#string

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

about

P2860

P2860

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932